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Rat adrenocortical carcinoma cells possess a high density of atria1 natriuretic factor (ANF) receptors which are coupled 
with membrane guanylate cyclase and corticosterone production. Herein we show that pretreatment of these cells with 
phorbol 12.myristate 13-acetate (PMA), a known activator of protein kinase C, attenuates the ANF-stimulated cyclic 
GMP accumulation in a dose-dependent manner. The half maximum inhibitory concentration of PMA was lo-‘0 M. 
When these cells were incubated with PMA in the presence of 1-(5isoquinolinyl-sulfonyl)-2-methyl piperazine, a protein 
kinase C inhibitor, the PMA-mediated attenuation of ANF-stimulated cyclic GMP formation is blocked. These results 
suggest that protein kinase C negatively regulates the ANF-receptor coupled membrane guanylate cyclase system in these 
cells. 
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1. INTRODUCTION 
Original studies with rat adrenocortical car- 
cinoma indicated a mediatory role of cyclic 
guanosine monophosphate (cyclic GMP) in ACTH 
and in az-adrenergic receptor mediated signal 
transduction as reviewed in [ 11. Until recently, this 
hypothesis was not widely accepted since there was 
a general disbelief in the existence of a distinct 
hormone-dependent membrane guanylate cyclase 
in any endocrine or nonendocrine tissue [2,3]. The 
reservations to this concept were overcome when 
two distinct types of guanylate cyclase - mem- 
brane and soluble - were demonstrated in rat 
adrenocortical carcinoma. Only the membrane en- 
zyme is hormone specific [4-61, but both 
mz-adrenergic receptor signals [7] and ACTH [4-61 
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are positively coupled to the membrane guanylate 
cyclase. The studies with isolated fasciculata cells 
of rat adrenal cortex [S], in vivo studies with rat 
adrenal gland [9] and in situ studies with mouse in- 
terstitial [lo] and Leydig cells [11,12], all of which 
indicate the second messenger role of cyclic GMP 
in ANF steroidogenic signal transduction may be 
of exceptional importance. Consistent with this 
concept is the isolation, biochemical and im- 
munological characterization of a homogeneous 
180 kDa membrane guanylate cyclase coupled 
ANF receptor from the steroid secreting 
adrenocortical carcinoma cells [ 131, which pro- 
vides a direct transmembrane biochemical ink be- 
tween the receptor and cyclic GMP formation. 
One of the regulatory mechanisms of cyclic GMP- 
mediated ANF signal transduction has now been 
offered by our demonstrating that phorbol ester 
signal, probably through protein kinase C, 
negatively regulates the ANF receptor-coupled 
membrane guanylate cyclase. 
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2. MATERIALS AND METHODS 
The isolated rat adrenocortical carcinoma cells were prepared 
by the trypsin digestion method [14,15]. The cells have been 
thoroughly characterized, morphologically and biochemically 
[ 15,161. The isolated adrenocortical carcinoma cells were 
suspended in Krebs-Ringer-bicarbonate buffer, pH 7.4, con- 
taining 4% albumin and 0.2% glucose. To study the influence 
of PMA on ANF-dependent cyclic GMP formation, the cells (5 
x 10’) were incubated at 37°C under 5% CO2/95% 02 with 
varying concentrations of PMA in the presence or absence of 
1 pM ANF in a total volume of 1.0 ml of Krebs-Ringer bicar- 
bonate buffer. Every incubation experiment was conducted in 
triplicate and repeated at least three times. Unless otherwise 
noted, the cells were preincubated for 10 min in the presence of 
PMA prior to initiation of the appropriate assay; PMA was pre- 
sent throughout the subsequent assay incubation period. The 
assay for cyclic GMP was conducted at 20 min. At the end of 
the incubation time, 1.0 ml of 1 M perchloric acid was added 
to terminate the reaction. The reaction mixture was neutralized 
by the addition of 10 M KOH and the tubes were centrifuged 
at 500 x g for 10 min. The cGMP levels were determined in the 
supernatant by radioimmunoassay [17]. To determine the par- 
ticulate guanylate cyclase activity changes in response to the 
PMA, the adrenocortical carcinoma cells (1 x 106) were prein- 
cubated with 1 pM PMA for 10 min and then another 20 min 
with 1 pM ANF at 37°C in the continuous presence of PMA. 
The cells were isolated by centrifugation at 600 x g, and were 
washed two times with Krebs-Ringer bicarbonate buffer. The 
washed cells were suspended in 1 .O ml of ice-cold 40 mM Tris- 
HCl buffer (pH 7.5), containing 10 mM MgC12,0.5 mM EDTA 
and 10 mM ,&mercaptoethanol (buffer A), and sonicated for 
15 s. The homogenate was centrifuged at 105000 x g for 60 min 
and the pellet was resuspended in the buffer A. Particulate 
guanylate cyclase activity was essentially assessed as described 
earlier [13]. The reaction mixture (0.1 ml) contained 10 mM 
theophylline, 15 mM creatine phosphate, 20 pg creatine kinase, 
1 mM CaC12, 1 mM MnC12, 4 mM GTP in 50 mM Tris buffer 
(pH 7.5) and 20 pl of enzyme suspension. The reaction was in- 
itiated by the addition of the substrate solution containing 
MgCl2 and GTP. Incubation was stopped after 20 min at 37°C 
by the addition of 0.9 ml of ice-cold 50 mM sodium phosphate 
buffer (pH 6.2). After centrifugation, the cGMP formed was 
determined by radioimmunoassay [ 171. 
ANF consisting of residues 8-33, was a kind gift from Dr 
Ruth F. Nutt, Merck Sharp and Dohme Research Laboratories; 
trypsin and soyabean trypsin inhibitors were from Cooper 
Biomedical and phorbol 12-myristate 13-acetate, w-phorbol 
and phorbol 12,13-didecanoate were purchased from Sigma. 
All other reagents were of analytical grade from commercial 
sources. 
3. RESULTS AND DISCUSSION 
Consistent with our previous results [8], ANF 
stimulated both the membrane guanylate cyclase 
and cyclic GMP formation in isolated rat 
adrenocortical carcinoma cells (fig. 1A). Sodium 
nitroprusside, an agent known to stimulate soluble 
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Fig. 1. (A) Dose dependence of cyclic GMP (0) and membrane 
guanylate cyclase (A) formation by ANF in rat adrenocortical 
carcinoma cells. Incubation system: 0.8 ml adrenocortical 
carcinoma cells suspension (5 x 10m5); reagents dissolved in 
0.2 ml Krebs-Ringer bicarbonate buffer with glucose and 
albumin; total volume of incubation mixture, 1.0 ml. The data 
summarize the results of 3 separate experiments, each of which 
contain triplicate cell incubation mixtures. The basal value of 
cyclic GMP (0.25 x 0.04 pmol) has been subtracted. Guanylate 
cyclase was assayed for 20 min as described [17]. Results are 
shown as the mean + SE (n = 3). Basal guanylate cyclase 
activity is 2.6 pmol/20 min per lo6 cells. (B) Concentration 
dependence of PMA inhibition of ANF-stimulated cyclic GMP 
formation. The rat adrenocortical carcinoma cells were treated 
with various concentrations of PMA for 10 min, and then 
exposed to 1 pM AMF for 20 min. Conditions were similar to 
those in A. Results are expressed as the mean values of three 
separate determinations k SE. (0) Without ANF, (0) with 
1 pM ANF. 
guanylate cyclase [3] but ineffective toward par- 
ticulate guanylate cyclase [S], did not stimulate 
cyclic GMP formation in the adrenocortical car- 
cinoma cells [6], thus indicating the selective cou- 
pling of particulate guanylate cyclase with the 
ANF receptor. To determine the interaction of 
phorbol ester signal transduction with basal and 
ANF-dependent cyclic GMP levels, the adrenocor- 
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tical carcinoma cells were incubated with varying 
concentrations of PMA (the active analog of phor- 
bol ester) in the presence or absence of 1 PM ANF, 
the concentration which causes the maximal for- 
mation of cyclic GMP. There was no effect on the 
basal level of cyclic GMP, but the ANF-dependent 
cyclic GMP rise was blocked by PMA in a 
concentration-dependent manner, with a Ki of 
lo-” M and with a complete block by 5 x lo-’ M 
(fig.lB). PMA also inhibited the hormonally 
dependent membrane guanylate cyclase (table 2). 
Since the phorbol ester receptor is protein kinase C 
[18,19], the results imply that this protein kinase is 
the mediator of the inhibitory signal. This inter- 
pretation is further supported by two types of 
observations. First, the two phorbol ester analogs, 
4fl phorbol and phorbol 12,13_didecanoate, which 
do not cause stimulation of protein kinase C, did 
not interfere with the ANF-dependent elevation of 
cyclic GMP levels (table 1). Second, a non-specific 
inhibitor of protein kinase C, 1-(5isoquinolinyl- 
sulfonyl)-tmethyl piperazine, [H-7], which has 
been shown to inhibit various cellular responses 
stimulated by protein kinase C activating phorbol 
esters [20,21], released the inhibition caused by 
PMA on the ANF-dependent increment of cyclic 
GMP levels (fig.2). 
In molecular terms the obvious mechanism by 
which protein kinase C could regulate the mem- 
brane guanylate cyclase activity is via the process 
of phosphorylation and dephosphorylation. In 
such a mechanism, protein kinase C would ter- 
Table 1 
Effects of various analogs of phorbol esters on the ANF- 
stimulated cyclic GMP level in isolated rat adrenocortical 
carcinoma cells 
Pretreatment cyclic GMP formed 
(pmol/20 min 
per 5 x IO5 cells) 
- ANF + ANF 
Basal 0.25 + 0.04 1.20 + 0.06 
PMA 0.21 * 0.03 0.30 f 0.02 
4cu-Phorbol 12,13-didecanoate 0.24 + 0.04 1.05 + 0.04 
@-Phorbol 0.20 + 0.02 0.90 + 0.04 
The cells (1 x 106) were preincubated with or without PMA 
(1 PM) for 10 min and then with or without 1 pM ANF for 
another 20 min in a total volume of 1.0 ml as described in 
section 2. The tubes were then centrifuged at 600 x g in an IEC 
centrifuge, model PR-I. The cells were washed twice with 
40 mM Tris-HCI buffer, pH 7.4; containing 10 mM M&12, 
0.5 mM EDTA and 10.0 mM /3-mercaptoethanol. The cells 
were sonicated for I5 s by a Branson sonifier cell disruptor, 
model 185, and the homogenate was centrifuged at 105000 x g 
for 60 min. The pellet was resuspended in the above buffer and 
Cells (5 x 10’) were incubated with various analogs of phorbol 
esters (1 ,zM) for 10 min and then another 20 min with or 
without 1 pM ANF in a total volume of 1 .O ml, and were then 
assayed for cyclic GMP formation as described in section 2. 
Values are means + SE (n = 3) guanylate cyclase activity was assayed as described [17] 
Fig.2. Effect of PMA, ANF and H-7 on the cyclic GMP 
formation in isolated adrenocortical carcinoma cells. The 
conditions of the experiments were identical to those in fig.1, 
except the tubes containing H-7 (lOOaM final) were 
preincubated together with PMA for 10 min and then 
stimulated with 1 pM ANF for another 20 min. Results are 
shown as the mean + SE (n = 3). 
minate the cyclic GMP-mediated signal transduc- 
tion by phosphorylation of the receptor-coupled 
guanylate cyclase and dephosphorylation of the 
enzyme which would cause the signal to be 
propagated. 
Membrane guanylate cyclase and protein kinase 
C interaction raises other interesting points. The 
two limbs of the phosphatidylinositol signal 
pathway are turned on by the activation of 
phosphatidylinositol 4,5_bisphosphate phospho- 
Table 2 
Effect of PMA on membrane guanylate cyclase activity in 
response to ANF in isolated adrenocorticl carcinoma cells 
Treatment Guanylate cyclase activity 
(pmol/20 min per IO6 cells) 
- ANF + ANF 
Cells treated without PMA 2.6 + 0.10 6.0 + 0.21 
Cells treated with PMA 2.4 k 0.06 2.5 + 0.12 
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diesterase which catalyzes the cleavage of phospha- 
tidylinositol4,5-bisphosphate into inositol triphos- 
phate (IP3) which in turn regulates the levels of in- 
tracellular calcium, and 1,2-diacylglycerol which 
activates protein kinase C. Analogous to the situa- 
tion with the phorbol ester receptor, the vaso- 
pressin receptor signal also negatively regulates the 
ANF-dependent formation of cyclic GMP and 
positively regulates the phosphatidylinositol turn- 
over [21]. The link between vasopressin and ANF 
receptor signals might also be protein kinase C. 
The cuz-adrenergic signal transduction positively 
regulates membrane guanylate cyclase and nega- 
tively regulates the adenylate cyclase [7]. Together, 
the results indicate that these transmembrane 
receptor signals in which cyclic GMP plays a bona 
fide second messenger role are intertwined. 
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